These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7326045)

  • 1. Prediction of drug-drug interaction from in vitro plasma protein binding and metabolism. A study of tolbutamide-sulfonamide interaction in rats.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Biochem Pharmacol; 1981 Dec; 30(24):3347-54. PubMed ID: 7326045
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetic analysis of tolbutamide-sulfonamide interaction in rabbits based on clearance concept. Prediction of species difference from in vitro plasma protein binding and metabolism.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    Drug Metab Dispos; 1984; 12(1):131-8. PubMed ID: 6141904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of drug-drug interactions in sheep: tolbutamide and sulfadimethoxine.
    Thiessen JJ; Rowland M
    J Pharm Sci; 1977 Aug; 66(8):1063-70. PubMed ID: 894490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiologically based pharmacokinetics of drug-drug interaction: a study of tolbutamide-sulfonamide interaction in rats.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharmacokinet Biopharm; 1982 Jun; 10(3):297-316. PubMed ID: 7175701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of sulfaphenazole and sulfadoxine on tolbutamide disposition in dwarf goats (Caprus hircus aegagrus).
    Zweers-Zeilmaker WM; Wildschut S; Witkamp RF; Van Miert AS
    Res Vet Sci; 1997; 63(3):269-72. PubMed ID: 9491455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of inhibition of tolbutamide metabolism: phenylbutazone, oxyphenbutazone, sulfaphenazole.
    Pond SM; Birkett DJ; Wade DN
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):573-9. PubMed ID: 913025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Binding of some sulfanilamides to blood proteins of man. 1. Determinations of low sulfanilamide concentrations in vitro at room temperature].
    Spring P
    Arzneimittelforschung; 1966 Mar; 16(3):346-54. PubMed ID: 6013844
    [No Abstract]   [Full Text] [Related]  

  • 8. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.
    Komatsu K; Ito K; Nakajima Y; Kanamitsu Si; Imaoka S; Funae Y; Green CE; Tyson CA; Shimada N; Sugiyama Y
    Drug Metab Dispos; 2000 Apr; 28(4):475-81. PubMed ID: 10725317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of t1/2 value for some sulfonamides in the mini-pig].
    Rossi T; Gaggi R; Cantelli-Forti G; Biagi GL
    Boll Soc Ital Biol Sper; 1978 Dec; 54(24):2499-503. PubMed ID: 756268
    [No Abstract]   [Full Text] [Related]  

  • 10. [Blood levels of long-acting sufonamides in horses after oral or intravenous administration].
    Oishi S; Nakajima T
    Nihon Juigaku Zasshi; 1964 Dec; 26(6):343-7. PubMed ID: 5896582
    [No Abstract]   [Full Text] [Related]  

  • 11. Binding of sulfonamides to erythrocyte proteins and possible drug-drug interaction.
    Matsumoto K; Miyazaki H; Fujii T; Amejima H; Furukawa H; Hashimoto M
    Chem Pharm Bull (Tokyo); 1989 Oct; 37(10):2807-10. PubMed ID: 2611942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of hemodialysis and the effects of certain displacing agents on plasma protein binding of sulfamethoxazole and sulfaphenazole in patients with chronic renal failure.
    Kawamura T; Yagi N; Sugawara H; Yamahata K; Takada M
    Chem Pharm Bull (Tokyo); 1980 Jan; 28(1):268-76. PubMed ID: 7363373
    [No Abstract]   [Full Text] [Related]  

  • 13. Hydrophobic bonding of sulfonamide drugs with serum albumin.
    Fujita T
    J Med Chem; 1972 Oct; 15(10):1049-56. PubMed ID: 4672194
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of peritoneal dialysis of tolbutamide in rats under conditions of the plasma unbound fraction being increased.
    Makita T; Aiba T; Izuwa Y; Komori Y; Kawasaki H; Kurosaki Y
    Biopharm Drug Dispos; 2009 Jan; 30(1):1-8. PubMed ID: 19148953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1977 Mar; 21(3):301-9. PubMed ID: 837649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of sulfonamides and sulfonamide potentiators between red blood cells, proteins and aqueous phases of the blood of different species.
    Berneis K; Boguth W
    Chemotherapy; 1976; 22(6):390-409. PubMed ID: 954483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.
    Miners JO; Foenander T; Wanwimolruk S; Gallus AS; Birkett DJ
    Eur J Clin Pharmacol; 1982; 22(4):321-6. PubMed ID: 7106168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sulfaphenazole on tolbutamide distribution in rabbits: analysis of interspecies differences in tissue distribution of tolbutamide.
    Sugita O; Sawada Y; Sugiyama Y; Iga T; Hanano M
    J Pharm Sci; 1984 May; 73(5):631-4. PubMed ID: 6737237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Demonstration of two trimethoprim/sulfonamide combinations in bronchoalveolar lavage fluid of horses and determination of blood levels].
    Fey K; Klatt P; Schmidt H; Sasse HH
    Tierarztl Prax; 1995 Feb; 23(1):59-65. PubMed ID: 7792777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cotrimoxazole as an inhibitor of oxidative drug metabolism: effects of trimethoprim and sulphamethoxazole separately and combined on tolbutamide disposition.
    Wing LM; Miners JO
    Br J Clin Pharmacol; 1985 Nov; 20(5):482-5. PubMed ID: 3878154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.